David K. Stone
I was born in 1956 in Denver, Colorado, five minutes after my twin brother Robert. Yes, we’re identical. As the youngest of five children, and with a co-conspirator always at hand, I had many childhood adventures. My father was a machinist and my mother a homemaker. We weren’t rich, but we never felt poor. Planning to become a veterinarian, I went to Colorado State University, where I earned a Bachelor of Science in Microbiology.
In 1981 I moved to Massachusetts to attend Harvard Business School. Two results of that decision have shaped my life since. I met my wife Carol through a classified ad. “Wanted, rush typist. Contact the Editor, Harbus News.” And I got my first job as a Project Manager at Genetics Institute, one of the pioneering companies creating products from recombinant DNA technology.
In 1989 I had a triple life crisis. My first child was born, I got a new job, and I moved from a Mac back to a PC. For the next ten years I followed the Biotechnology Industry as a research analyst for Cowen & Company. Life on Wall Street was better back then. I joined Flagship Ventures in 2000 and spent seven years investing in early-stage life sciences companies. Since 2006 I’ve been an independent consultant and investment banker, helping start-ups with strategy, finance and communications.
Over nearly 30 years in biotechnology I’ve experienced cool science, colorful characters, gourmet food, international travel, and the full range of human emotions. So I’ve used these ingredients in my techno-thriller novel Cloned Genes. I hope you enjoy reading the book as much as I did writing it.
I live in a 1710 colonial in Acton, Massachusetts called the Liberty Tree House. My wife and I own and manage Liberty Tree Farm. Besides our two children, we share the place with 19 horses, three cats and a few laying hens. If you are in the area, feel free to stop by.
Doctor Caroline O’Reilly is a rising star in trauma surgery at Massachusetts General Hospital. At five-foot-ten with red hair and green eyes she can look a man in the eye and know that he’ll be looking back. Still single at 36, but recently in love, she’s got her personal life and career in balance. Then one day a special patient dies. This one man’s death calls all her skill and judgment into question. Searching for answers she discovers a criminal conspiracy entwining the science and business of biotechnology. Thousands of patients, millions of dollars and her life are at stake. Can she unravel the mystery in time?